RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA (PTCL)

Clinical trials for RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA (PTCL) explained in plain language.

Never miss a new study

Get alerted when new RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA (PTCL) trials appear

Sign up with your email to follow new studies for RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA (PTCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for patients out of options: experimental drug targets tough blood cancers

Disease control Ongoing

This study is testing an experimental drug called Purinostat mesylate in patients with advanced T-cell lymphomas that have returned or stopped responding to standard treatments. The main goal is to see if the drug can shrink tumors and control the disease. Researchers will also c…

Matched conditions: RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA (PTCL)

Phase: PHASE2 • Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd • Aim: Disease control

Last updated Mar 31, 2026 12:10 UTC

RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA (PTCL)

Get alerted when new RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA (PTCL) trials appear

New hope for patients out of options: experimental drug targets tough blood cancers